<a href="https://www.fiercebiotech.com/biotech/american-biotech-innovation-alliance-debuts-unify-domestic-strategy-amid-global-threats" hreflang="en">The American Biotech Innovation Alliance launches to unify domestic strategy amid global competition</a>
The American Biotech Innovation Alliance (ABIA) has been launched by a group of biotech leaders to unify stakeholders and establish a national strategy aimed at sustaining U.S. leadership in biotech innovation amid rising global competition, particularly from China. The alliance plans to produce a report outlining necessary policy and investment priorities while fostering collaboration among industry members without directly lobbying lawmakers.
The launch of the American Biotech Innovation Alliance (ABIA) signifies a strategic move to consolidate U.S. leadership in biotech by unifying stakeholders and addressing urgent challenges like declining public investment and global competition, particularly from China. For professionals in healthtech and biotech, this presents an opportunity to engage with ABIA’s initiatives, contributing to policy and investment strategies that could influence the future landscape and competitive edge of the U.S. biotech sector.